Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on INT 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111057052B enables selective synthesis. Reduces costs and improves supply chain reliability for global pharmaceutical manufacturers.
Patent CN110437092A reveals a streamlined one-step synthesis for Ticagrelor intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN103819325B reveals a one-step copper-catalyzed cyclization for OLED intermediates, offering significant cost reduction and supply chain reliability for electronic chemical manufacturing.
Patent CN105461606A reveals enzymatic hydrolysis for Ledipasvir intermediates. Achieve >99% de purity and scalable green manufacturing for Hepatitis C drug supply chains.
Novel patent CN106866739B offers high-yield synthesis for TAF intermediates. Reduces steps, improves scalability for reliable pharmaceutical intermediate supply chains.
Patent CN115850115B reveals high-purity Ruxolitinib intermediate synthesis. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Patent CN113292495B details a high-yield synthesis of (S)-amino benazepril intermediate using quinine-derived catalysis, offering significant cost and safety advantages for API manufacturing.
Patent CN105263913B details a safer thio-1,2,4-triazole synthesis route offering high purity and cost reduction in API manufacturing for global supply chains.
Patent CN105348144B details a high-purity synthetic route for Simeprevir intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel patent CN103159705B offers high-yield cabazitaxel intermediate synthesis. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Advanced Pd-catalyzed route for Palbociclib Intermediate II. High yield, cost-effective process for API manufacturing.
Patent CN111116501B details a novel catalytic method for synthesizing Lesinurad intermediates, eliminating chlorinated impurities and ensuring scalable API production.
Novel synthetic method for Biotin key intermediate reduces cost and complexity. Reliable supply chain partner for pharmaceutical manufacturing ensuring high purity and scalability.
Novel preparation method controls water content below 0.03%. Enhances oxidation selectivity and yield for esomeprazole manufacturing.
Patent CN104327039A reveals enzymatic synthesis for rosuvastatin intermediate offering milder conditions and reduced solvent consumption for supply chain optimization.
Patent CN105837493A offers mild condition Nintedanib synthesis. Enhances yield and supply chain stability for pharmaceutical intermediates manufacturing globally.
Patent CN101362752B details a safer synthesis of Lamivudine intermediates using Triphosgene, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN104356069B reveals optimized Grignard route reducing impurities. Enables cost reduction in pharma intermediate manufacturing and reliable supply chain.
Novel copper-catalyzed route reduces costs and improves purity for insomnia drug intermediates, ensuring supply chain stability and commercial scalability.
Patent CN106660949B reveals a safe, scalable chiral resolution method for TRPV1 antagonist intermediates, offering significant cost reduction in API manufacturing.